Alejandro Costaguta

Summary

Publications

  1. doi request reprint Successful treatment of refractory autoimmune hepatitis with rituximab
    Daniel D'Agostino
    Pediatric Gastroenterology Hepatology Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
    Pediatrics 132:e526-30. 2013
  2. doi request reprint [The new paradigm of neonatal hemochromatosis: fetal alloimmune hepatitis]
    Alejandro Costaguta
    Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Rosario, Argentina
    Arch Argent Pediatr 110:237-43. 2012

Collaborators

  • Daniel D'Agostino
  • Fernando Alvarez

Detail Information

Publications2

  1. doi request reprint Successful treatment of refractory autoimmune hepatitis with rituximab
    Daniel D'Agostino
    Pediatric Gastroenterology Hepatology Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
    Pediatrics 132:e526-30. 2013
    ..We describe a new rescue therapy using anti-CD20 monoclonal antibodies (rituximab). Complete remission was obtained and maintained by using low doses of immunosuppressive drugs with repeated anti-CD20 infusions...
  2. doi request reprint [The new paradigm of neonatal hemochromatosis: fetal alloimmune hepatitis]
    Alejandro Costaguta
    Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Rosario, Argentina
    Arch Argent Pediatr 110:237-43. 2012
    ..This new paradigm produces a deep impact in diagnosis, prognosis and treatment of the disease, that should be called "fetal alloimmune hepatitis"...